{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:02:29Z","timestamp":1786982549420,"version":"build-2736575974"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,7,14]],"date-time":"2016-07-14T00:00:00Z","timestamp":1468454400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1055176"],"award-info":[{"award-number":["1055176"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["ID1061041"],"award-info":[{"award-number":["ID1061041"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["ID1002611"],"award-info":[{"award-number":["ID1002611"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["ID1114284"],"award-info":[{"award-number":["ID1114284"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Med. Toxicol."],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1007\/s13181-016-0574-4","type":"journal-article","created":{"date-parts":[[2016,7,14]],"date-time":"2016-07-14T09:59:35Z","timestamp":1468490375000},"page":"88-90","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Severe Hypertension and Bradycardia Secondary to Midodrine Overdose"],"prefix":"10.1007","volume":"13","author":[{"given":"L. Y.","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. K.","family":"Isbister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,7,14]]},"reference":[{"key":"574_CR1","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/0002-9343(93)90230-M","volume":"95","author":"J Jankovic","year":"1993","unstructured":"Jankovic J, Hiner B, Brown D, Rubin M. Neurogenic orthostatic hypotension: a double-blind placebo-controlled study with midodrine. Am J Med. 1993;95:38\u201348.","journal-title":"Am J Med"},{"key":"574_CR2","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1212\/WNL.0000000000000815","volume":"83","author":"A Izcovich","year":"2014","unstructured":"Izcovich A, Malla C, Manzotti M, Catalano H, Guyatt G. Midodrine for orthostatic hypotension and recurrent reflex syncope: a systematic review. Neurology. 2014;83:1170\u20137.","journal-title":"Neurology"},{"key":"574_CR3","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1517\/14740338.2.1.37","volume":"2","author":"M Perazella","year":"2003","unstructured":"Perazella M. Efficacy and safety of midodrine in the treatment of dialysis-associated hypotension. Expert Opin Drug Saf. 2003;2:37\u201347.","journal-title":"Expert Opin Drug Saf"},{"key":"574_CR4","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1136\/hrt.79.1.45","volume":"79","author":"C Ward","year":"1998","unstructured":"Ward C, Gray J, Gilroy J, Kenny R. Midodrine: a role in the management of neurocardiogenic syncope. Heart. 1998;79:45\u20139.","journal-title":"Heart"},{"key":"574_CR5","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/clpt.1986.101","volume":"39","author":"P Zachariah","year":"1986","unstructured":"Zachariah P, Moyer T, Fealey R. Pharmacodynamics of midodrine, an antihypotensive agent. Clin Pharmacol Ther. 1986;39:586\u201391.","journal-title":"Clin Pharmacol Ther"},{"key":"574_CR6","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/ana.10293","volume":"52","author":"H Kaufmann","year":"2002","unstructured":"Kaufmann H, Saadia D, Voustianiouk A. Midodrine in neutrally mediated syncope: a double blind, randomized, crossover study. Ann Neurol. 2002;52:342\u20135.","journal-title":"Ann Neurol"},{"key":"574_CR7","doi-asserted-by":"crossref","first-page":"757","DOI":"10.2165\/00003495-198938050-00004","volume":"38","author":"D McTavish","year":"1989","unstructured":"McTavish D, Goa K. Midodrine: a review of its pharmacologic properties and therapeutic use in orthostatic hypotension and secondary hypotensive disorders. Drugs. 1989;38:757\u201377.","journal-title":"Drugs"},{"key":"574_CR8","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1001\/jama.1997.03540370036033","volume":"277","author":"P Low","year":"1997","unstructured":"Low P, Gilden J, Freeman R, Sheng K, McElligott M. Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. JAMA. 1997;277:1046\u201351.","journal-title":"JAMA"},{"key":"574_CR9","unstructured":"Hofer K, Rauber-Luthy C, Kupferschmidt H, Ceschi A. Acute midodrine overdose: a case series (abstract). Clin Toxicol 2012;50:362"},{"key":"574_CR10","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00246-006-0169-y","volume":"28","author":"S Olgar","year":"2007","unstructured":"Olgar S, Omeroglu R. Prolonged supine hypertension due to midodrine use in an orthostatic hypotensive child. Pediatr Cardiol. 2007;28:309\u201310.","journal-title":"Pediatr Cardiol"},{"key":"574_CR11","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0140-6736(00)02539-3","volume":"356","author":"C Vaughan","year":"2000","unstructured":"Vaughan C, Delanty N. Hypertensive emergencies. Lancet. 2000;356:411\u20137.","journal-title":"Lancet"}],"container-title":["Journal of Medical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13181-016-0574-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13181-016-0574-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13181-016-0574-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13181-016-0574-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T14:24:19Z","timestamp":1498314259000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13181-016-0574-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,14]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["574"],"URL":"https:\/\/doi.org\/10.1007\/s13181-016-0574-4","relation":{},"ISSN":["1556-9039","1937-6995"],"issn-type":[{"value":"1556-9039","type":"print"},{"value":"1937-6995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,14]]}}}